EFFECTS OF LONG-TERM TREATMENT WITH ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR ON ANGIOTENSIN-II AND PROSTACYCLIN RELEASE FROM MESENTERIC-ARTERIES IN SPONTANEOUSLY HYPERTENSIVE RATS
M. Ito et al., EFFECTS OF LONG-TERM TREATMENT WITH ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR ON ANGIOTENSIN-II AND PROSTACYCLIN RELEASE FROM MESENTERIC-ARTERIES IN SPONTANEOUSLY HYPERTENSIVE RATS, Prostaglandins, leukotrienes and essential fatty acids, 53(5), 1995, pp. 359-363
To evaluate the long-term effects of an angiotensin-converting enzyme
inhibitor (ACEI) on vascular angiotensin II (AII), eicosanoid producti
on and vascular reactivities, we treated spontaneously hypertensive ra
ts (SHR) with alacepril for 6 weeks and perfused the isolated mesenter
ic arterial bed which contains resistance vessels, Alacepril significa
ntly lowered the arterial blood pressure, Changes in perfusion pressur
e in response to norepinephrine (NE) were attenuated, and isoprotereno
l-stimulated AII release from the perfused mesenteric arterial beds wa
s inhibited in the alacepril-treated SHR, Vasodilation induced by acet
ylcholine (Ach) and prostacyclin (PGI(2)) release was significantly in
creased in the vasculature of the alacepril-treated SHR, Alacepril exe
rted no effect on cyclic GMP (cGMP) formation, but increased cAMP form
ation in the vasculature, These findings suggest that ACEI inhibits AI
I formation and facilitates PGI(2) production in the resistance vessel
s, which leads to blunting of the presser response to NE and improveme
nt of endothelial function in SHR, These humoral and mechanical change
s in the vasculature may contribute to the depressor and organ protect
ive effects of ACEI.